Tommy G. Thompson
Tommy G. Thompson's purchase track record
How the stock did after each of Tommy G. Thompson's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/23/2025 | TXMD | $14K | +39.6% | +21.9% | +6.6% |
| 5/28/2025 | DOC | $100K | +4.6% | +8.3% | +15.7% |
| 5/9/2025 | DOC | $99K | -1.2% | +5.5% | +18.9% |
| 4/14/2025 | TXMD | $326 | +13.6% | +1.9% | +23.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Healthpeak Sets Q3 2026 Earnings Date and Declares Q4 Dividend. Healthpeak Properties announced the dates for its third‑quarter 2026 earnings release, conference call, and webcast. The company also declared a monthly common‑stock cash dividend for the fourth quarter of 2026. These updates give investors a schedule for upcoming earnings and confirm the firm’s continued dividend payments, which can influence trading activity.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Centene Expands CHOICE Arrangements in Indiana, Ohio, Oklahoma. Centene has rolled out new benefit programs that support its CHOICE arrangements in Indiana, Ohio and Oklahoma, signaling a push to broaden its managed care footprint. Analysts note the company’s turnaround still has room to grow, and its target price remains well above the current level. The broader managed‑care landscape is also shifting, with UnitedHealth reporting higher margins but lower membership, a trend that may influence competitive dynamics.
Transaction History
| UTHR | ▲ Buy | Option Exercise | 2,000 | $204K | 3/26/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 275 | $148K | 3/26/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,414 | $762K | 3/26/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 311 | $168K | 3/26/2026 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,000 | $204K | 3/4/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,000 | $979K | 3/4/2026 | View on chart |
| TXMD | ▲ Buy | Open Market | 8,400 | $14K | 12/23/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 910 | $93K | 12/18/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 910 | $456K | 12/18/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 4,560 | $1.0M | 9/10/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 4,560 | $1.8M | 9/10/2025 | View on chart |
| DOC | ▲ Buy | Open Market | 5,777 | $100K | 5/28/2025 | View on chart |
| DOC | ▲ Buy | Open Market | 5,700 | $99K | 5/9/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $439K | 5/9/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,500 | $763K | 5/9/2025 | View on chart |
| DOC | ▲ Buy | Grant | 10,657 | $0 | 4/25/2025 | View on chart |
| TXMD | ▲ Buy | Open Market | 325 | $326 | 4/14/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $439K | 3/24/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,500 | $797K | 3/24/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $439K | 2/28/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 2,500 | $796K | 2/28/2025 | View on chart |
| TXMD | ▲ Buy | Option Exercise | 8,500 | $0 | 2/18/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 7,500 | $1.3M | 6/26/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 1,515 | $485K | 6/26/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 900 | $289K | 6/26/2024 | View on chart |
| UTHR | ▼ Sell | Open Market | 5,085 | $1.6M | 6/26/2024 | View on chart |
| DOC | ▲ Buy | Grant | 9,575 | $0 | 4/26/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 5,000 | $440K | 3/11/2024 | View on chart |
| UTHR | ▼ Sell | Other | 5,000 | $1.2M | 3/11/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,000 | $176K | 3/8/2024 | View on chart |
| UTHR | ▼ Sell | Other | 2,000 | $486K | 3/8/2024 | View on chart |
| UTHR | ▼ Sell | Other | 2,000 | $474K | 3/6/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,000 | $176K | 3/6/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,000 | $176K | 3/1/2024 | View on chart |
| UTHR | ▼ Sell | Other | 2,000 | $464K | 3/1/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,000 | $176K | 2/23/2024 | View on chart |
| UTHR | ▼ Sell | Other | 2,000 | $454K | 2/23/2024 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 880 | $0 | 7/7/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,000 | $88K | 6/13/2023 | View on chart |
| UTHR | ▼ Sell | Other | 1,000 | $230K | 6/13/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,000 | $88K | 6/2/2023 | View on chart |
| UTHR | ▼ Sell | Other | 1,000 | $217K | 6/2/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $160K | 3/31/2023 | View on chart |
| UTHR | ▼ Sell | Other | 2,500 | $560K | 3/31/2023 | View on chart |
| UTHR | ▼ Sell | Other | 2,500 | $615K | 3/28/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $160K | 3/24/2023 | View on chart |
| UTHR | ▼ Sell | Other | 2,500 | $548K | 3/24/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $160K | 3/3/2023 | View on chart |
| UTHR | ▼ Sell | Other | 2,500 | $622K | 3/3/2023 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,500 | $160K | 2/28/2023 | View on chart |
| UTHR | ▼ Sell | Other | 5,000 | $1.3M | 11/23/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 5,000 | $320K | 11/23/2022 | View on chart |
| TXMD | ▲ Buy | Option Exercise | 2,976 | — | 8/18/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,080 | $0 | 7/8/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 2,200 | $106K | 5/26/2022 | View on chart |
| UTHR | ▼ Sell | Other | 2,200 | $495K | 5/26/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,500 | $72K | 3/29/2022 | View on chart |
| UTHR | ▼ Sell | Other | 1,500 | $268K | 3/29/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,509 | $73K | 3/17/2022 | View on chart |
| UTHR | ▼ Sell | Other | 1,509 | $278K | 3/17/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,500 | $72K | 3/16/2022 | View on chart |
| UTHR | ▼ Sell | Other | 1,500 | $274K | 3/16/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,500 | $72K | 3/15/2022 | View on chart |
| UTHR | ▼ Sell | Other | 1,500 | $268K | 3/15/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,000 | $48K | 3/10/2022 | View on chart |
| UTHR | ▼ Sell | Other | 1,000 | $168K | 3/10/2022 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 1,500 | $72K | 3/3/2022 | View on chart |
| UTHR | ▼ Sell | Other | 1,500 | $262K | 3/3/2022 | View on chart |
| CNC | ▲ Buy | Grant | 450 | $0 | 12/31/2021 | View on chart |
| CNC | ▲ Buy | Grant | 524 | $35K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
United Therapeutics Settles Litigation, Market Reassesses Valuation
United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.
United Therapeutics Settles Litigation, Market Reassesses Valuation. United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.